| 1. |
中華醫學會腎臟病學分會專家組. 抗中性粒細胞胞質抗體相關腎炎診斷和治療中國指南. 中華腎臟病雜志, 2021, 37(7): 603-620.
|
| 2. |
Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis, 2009, 68(12): 1827-1832.
|
| 3. |
Karras A, Lazareth H, Chauvet S. B-cell treatment in ANCA-associated vasculitis. Rheumatology (Oxford), 2020, 59(Suppl 3): iii68-iii73.
|
| 4. |
Cortazar FB, Muhsin SA, Pendergraft WF 3rd, et al. Combination therapy with rituximab and cyclophosphamide for remission induction in ANCA vasculitis. Kidney Int Rep, 2017, 3(2): 394-402.
|
| 5. |
Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. KDIGO 2024 clinical practice guideline for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Kidney Int, 2024, 105(3S): S71-S116.
|
| 6. |
Connelly-Smith L, Alquist CR, Aqui NA, et al. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue. J Clin Apher, 2023, 38(2): 77-278.
|
| 7. |
Cheng L, Tang YQ, Yi J, et al. Double filtration plasmapheresis in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis with severe kidney dysfunction. Blood Purif, 2020, 49(6): 713-722.
|
| 8. |
程芝靈, 孫桂香, 林輝, 等. 血漿置換治療肝衰竭臨床療效和安全性的 Meta 分析. 中國循證醫學雜志, 2015, 15(6): 664-671.
|
| 9. |
Liu JF, Wang WX, Xue J, et al. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late on set myasthenia gravis. Ther Apher Dial, 2010, 14(2): 153-160.
|
| 10. |
Zhang YY, Tang Z, Chen DM, et al. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis. BMC Nephrol, 2014, 15: 128.
|
| 11. |
Winters JL. Apheresis in the treatment of idiopathic dilated cardiomyopathy. J Clin Apher, 2012, 27(6): 312-319.
|
| 12. |
Stegmayr BG, Almroth G, Berlin G, et al. Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study. Int J Artif Organs, 1999, 22(2): 81-87.
|
| 13. |
Maillard N, Absi L, Claisse G, et al. Protein A-based immunoadsorption is more efficient than conventional plasma exchange to remove circulating anti-HLA antibodies. Blood Purif, 2015, 40(2): 167-172.
|
| 14. |
杜云英, 張旭峰, 陳校園, 等. 重組蛋白 A 免疫吸附劑的制備及吸附性能. 北京化工大學學報(自然版), 2011, 38(3): 92-96.
|
